Patient-derived monoclonal antibody neutralizes HCV infection in vitro and vivo without generating escape mutants

In recent years, new direct-acting antivirals for hepatitis C virus (HCV) have been approved, but hepatitis C continues to pose a threat to human health. It is important to develop neutralizing anti-HCV antibodies to prevent medical and accidental infection, such as might occur via liver transplanta...

Descripción completa

Detalles Bibliográficos
Autores principales: Yokokawa, Hiroshi, Shinohara, Midori, Teraoka, Yuji, Imamura, Michio, Nakamura, Noriko, Watanabe, Noriyuki, Date, Tomoko, Aizaki, Hideki, Iwamura, Tomokatsu, Narumi, Hideki, Chayama, Kazuaki, Wakita, Takaji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9499215/
https://www.ncbi.nlm.nih.gov/pubmed/36137152
http://dx.doi.org/10.1371/journal.pone.0274283

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9499215/
https://www.ncbi.nlm.nih.gov/pubmed/36137152
http://dx.doi.org/10.1371/journal.pone.0274283

Ejemplares similares